Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended-spectrum beta-lactamase: Can they be successfully treated with cephalosporins?

Escolà-Vergé L, Larrosa N, Los-Arcos I, Viñado B, González-López JJ, Pigrau C, Almirante B, Len O.

J Glob Antimicrob Resist. 2019 Dec;19:28-31. doi: 10.1016/j.jgar.2019.02.016. Epub 2019 Feb 27.

PMID:
30825700
2.

In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.

Aktaş Z, Kayacan C, Oncul O.

Int J Antimicrob Agents. 2012 Jan;39(1):86-9. doi: 10.1016/j.ijantimicag.2011.09.012. Epub 2011 Oct 29.

PMID:
22041508
3.

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.

Zhanel GG, Golden AR, Zelenitsky S, Wiebe K, Lawrence CK, Adam HJ, Idowu T, Domalaon R, Schweizer F, Zhanel MA, Lagacé-Wiens PRS, Walkty AJ, Noreddin A, Lynch Iii JP, Karlowsky JA.

Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Review.

PMID:
30712199
4.

Prevalence of Extended Spectrum β-lactamase-Producing Klebsiella pneumoniae in Clinical Isolates.

Ali Abdel Rahim KA, Ali Mohamed AM.

Jundishapur J Microbiol. 2014 Nov;7(11):e17114. doi: 10.5812/jjm.17114. Epub 2014 Nov 1.

5.
6.

Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.

Han SB, Jung SW, Bae EY, Lee JW, Lee DG, Chung NG, Jeong DC, Cho B, Kang JH, Kim HK, Park YJ.

Microb Drug Resist. 2015 Apr;21(2):244-51. doi: 10.1089/mdr.2014.0092. Epub 2014 Nov 14.

PMID:
25398058
7.

Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.

Chopra T, Marchaim D, Johnson PC, Chalana IK, Tamam Z, Mohammed M, Alkatib S, Tansek R, Chaudhry K, Zhao JJ, Pogue JM, Kaye KS.

Am J Infect Control. 2015 Jul 1;43(7):719-23. doi: 10.1016/j.ajic.2015.02.030. Epub 2015 Apr 29.

PMID:
25934068
9.

Local prevalence of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in Klebsiella pneumoniae: a prevalence survey in a Spanish University Hospital.

Díaz-Agero Pérez C, López-Fresneña N, Rincon Carlavilla AL, Hernandez Garcia M, Ruiz-Garbajosa P, Aranaz-Andrés JM, Maechler F, Gastmeier P, Bonten MJM, Canton R.

BMJ Open. 2019 Mar 1;9(3):e024879. doi: 10.1136/bmjopen-2018-024879.

11.

AmpC β-lactamases in nosocomial isolates of Klebsiella pneumoniae from India.

Gupta V, Kumarasamy K, Gulati N, Garg R, Krishnan P, Chander J.

Indian J Med Res. 2012 Aug;136(2):237-41.

12.

Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.

Boix-Palop L, Xercavins M, Badía C, Obradors M, Riera M, Freixas N, Pérez J, Rodríguez-Carballeira M, Garau J, Calbo E.

Int J Antimicrob Agents. 2017 Aug;50(2):197-202. doi: 10.1016/j.ijantimicag.2017.03.009. Epub 2017 May 24.

PMID:
28552471
14.
15.

Molecular Characterization of Extended Spectrum β-lactamase and Carbapenemase Producing Klebsiella pneumoniae from a Tertiary Care Hospital.

Bhaskar BH, Mulki SS, Joshi S, Adhikary R, Venkatesh BM.

Indian J Crit Care Med. 2019 Feb;23(2):61-66. doi: 10.5005/jp-journals-10071-23118.

16.

In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.

Kiremitci A, Dinleyici EC, Erben N, Durmaz G, Yargic ZA, Aybey AD, Usluer G.

Expert Opin Pharmacother. 2008 Jun;9(9):1441-9. doi: 10.1517/14656566.9.9.1441 .

PMID:
18518776
17.

Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.

Jean SS, Lee WS, Bai KJ, Lam C, Hsu CW, Yu KW, Liao CH, Chang FY, Ko WC, Wu JJ, Chen YH, Chen YS, Liu JW, Lu MC, Liu CY, Chen RJ, Hsueh PR.

J Microbiol Immunol Infect. 2015 Feb;48(1):85-91. doi: 10.1016/j.jmii.2013.07.002. Epub 2013 Aug 22.

18.

Carbapenem resistance due to Bla(OXA-48) among ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates in a univesity hospital, Turkey.

Nazik H, Ongen B, Ilktac M, Aydin S, Kuvat N, Sahin A, Yemisen M, Mete B, Durmus MS, Balkan II, Yildiz I, Ergul Y.

Southeast Asian J Trop Med Public Health. 2012 Sep;43(5):1178-85.

PMID:
23431824
19.

Extended-Spectrum Beta-Lactamases Producing Escherichia coli and Klebsiella pneumoniae: A Multi-Centric Study Across Karnataka.

Rao SP, Rama PS, Gurushanthappa V, Manipura R, Srinivasan K.

J Lab Physicians. 2014 Jan;6(1):7-13. doi: 10.4103/0974-2727.129083.

20.

Detection of OXA-1 β-lactamase gene of Klebsiella pneumoniae from blood stream infections (BSI) by conventional PCR and in-silico analysis to understand the mechanism of OXA mediated resistance.

Sugumar M, Kumar KM, Manoharan A, Anbarasu A, Ramaiah S.

PLoS One. 2014 Mar 19;9(3):e91800. doi: 10.1371/journal.pone.0091800. eCollection 2014.

Supplemental Content

Support Center